Virabiotics’s MolluscuDerm(TM) Topical Antiviral Therapy Launches At American Academy of Dermatology Meeting Feb. 2-5, 2007

LAKE JESSAMINE, Fla.--(BUSINESS WIRE)--Virabiotics, Inc., announced today that their topical antiviral therapy, MolluscuDermTM, is being launched as a new product at the American Academy of Dermatology Annual Meeting in Washington, DC, February 2-5.